MedTech Dive November 29, 2023
Nick Paul Taylor

The actions include using the Defense Production Act to enable investment in U.S. manufacturing of essential medicines and medical countermeasures, such as diagnostics.

Dive Brief:

  • President Joe Biden unveiled a list of new actions Monday to strengthen U.S. supply chains, including using the Defense Production Act (DPA) to enable investment in the manufacturing of medicines and medical countermeasures, such as diagnostic tests and personal protective equipment.
  • Biden, who took office as the COVID-19 pandemic was disrupting the flow of goods, framed the actions as a way to strengthen supply chains, enable reliable deliveries for businesses and create U.S. jobs. Along with the announcement, Biden held the inaugural meeting of a new cabinet-level White House council on logistics resilience
  • Medtech...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Congress / White House, Govt Agencies, HHS, Medical Devices, Pharma, Pharma / Biotech, Supply Chain, Technology
Related Articles:
Oracle shares jump 7% on involvement in AI infrastructure initiative that Trump will announce
How did health insurance coverage changes affect older adults? Two studies take a look
What Trump and the GOP have planned for healthcare
Moderna gets $590M from US government for bird flu vaccine
Employers sue to block mental health parity rule: 5 notes

Share This Article